Home
>
National Drug Code (NDC)
>
ELIPHOS
ELIPHOS - 0179-0098-70 - (Calcium Acetate)
Drug Information of ELIPHOS
| Product NDC: | 0179-0098 |
| Proprietary Name: | ELIPHOS |
| Non Proprietary Name: | Calcium Acetate |
| Active Ingredient(s): | 667 mg/1 & nbsp; Calcium Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ELIPHOS
| Product NDC: | 0179-0098 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078502 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110824 |
Package Information of ELIPHOS
| Package NDC: | 0179-0098-70 |
| Package Description: | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0098-70) |
NDC Information of ELIPHOS
| NDC Code | 0179-0098-70 |
| Proprietary Name | ELIPHOS |
| Package Description | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0098-70) |
| Product NDC | 0179-0098 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Calcium Acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110824 |
| Marketing Category Name | ANDA |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | CALCIUM ACETATE |
| Strength Number | 667 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |
